Liu Chen, Cheng Xiawei, Chen Juntao, Wang Yao, Wu Xiaoying, Tian Rui, Liu Baoqing, Ding Xianfeng, Sun Qiming, Gong Weihua
Department of Surgery, Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou 310058, China.
Department of Biochemistry, and Department of Cardiology of Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
Theranostics. 2019 May 31;9(13):3840-3852. doi: 10.7150/thno.33370. eCollection 2019.
: Biological mechanisms that control liver regeneration remain poorly defined. However, these mechanisms are remarkable issues in the clinic that affect management of hepatic loss caused by liver surgery, traumatic injury, chronic infection, or liver poisoning. Increasing evidence has shown that various growth factors, cytokines, and metabolic signaling pathways affect the liver regenerative process. Our aim is to study the effect of bromodomain and extraterminal (BET) protein inhibition on liver regeneration and its mechanism. : We studied the role of BET protein inhibitor, JQ1, in liver regeneration in a mouse model after 70% partial hepatectomy (PH). We evaluated yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ) and Notch signaling pathways, which were affected by BET protein inhibitor in mouse hepatic tissues and primary hepatocytes and AML12 cell lines . We evaluated the relationship of YAP/TAZ and Notch signaling pathway using YAP/TAZ pathway inhibitor in liver regeneration . Moreover, we analyzed the relationship of YAP/TAZ and Notch signaling pathways via overexpression or RNA silencing of in AML12 cells. Furthermore, we used overexpression mouse model to examine whether it can rescue liver regeneration damage caused by inhibition of BET proteins. : In this study, we report that BET protein inhibitor JQ1 molecule impairs the early phase of liver regeneration in a mouse model after 70% PH. Mechanistically, YAP/TAZ and Notch1-NICD pathways were suppressed by BET protein inhibitor in mouse hepatic tissues and primary hepatocytes and mouse AML12 cell lines . By using YAP/TAZ pathway inhibitor, we confirmed that the liver regeneration and the activation of Notch pathway were impaired by the inhibition of YAP/TAZ pathway . Furthermore, the study showed that knockdown by shRNA in normal mouse hepatic cell line downregulated Notch1 signal transduction, whereas overexpression promoted Notch1-NICD signals. Specific overexpression of in mouse liver could rescue the effect of BET protein inhibition on liver regeneration injury. : These results revealed the crucial role of the YAP/TAZ-Notch1-NICD axis in liver regeneration. Therefore, BET protein inhibitors must be used in caution in the treatment of hepatic diseases by reason of its suppressive roles in liver regeneration.
控制肝脏再生的生物学机制仍未完全明确。然而,这些机制在临床上是影响因肝脏手术、创伤性损伤、慢性感染或肝中毒导致的肝组织损失管理的重要问题。越来越多的证据表明,多种生长因子、细胞因子和代谢信号通路会影响肝脏再生过程。我们的目的是研究溴结构域和额外末端(BET)蛋白抑制对肝脏再生的影响及其机制。
我们研究了BET蛋白抑制剂JQ1在70%部分肝切除(PH)后小鼠模型肝脏再生中的作用。我们评估了Yes相关蛋白(YAP)/含PDZ结合基序的转录共激活因子(TAZ)和Notch信号通路,它们在小鼠肝组织、原代肝细胞和AML12细胞系中受到BET蛋白抑制剂的影响。我们使用YAP/TAZ通路抑制剂评估了肝脏再生中YAP/TAZ与Notch信号通路的关系。此外,我们通过在AML12细胞中过表达或RNA沉默来分析YAP/TAZ与Notch信号通路的关系。此外,我们使用过表达小鼠模型来研究它是否可以挽救由BET蛋白抑制引起的肝脏再生损伤。
在本研究中,我们报告BET蛋白抑制剂JQ1分子在70% PH后的小鼠模型中损害肝脏再生的早期阶段。机制上,YAP/TAZ和Notch1-NICD通路在小鼠肝组织、原代肝细胞和小鼠AML12细胞系中被BET蛋白抑制剂抑制。通过使用YAP/TAZ通路抑制剂,我们证实YAP/TAZ通路的抑制会损害肝脏再生和Notch通路的激活。此外,研究表明,在正常小鼠肝细胞系中通过shRNA敲低会下调Notch1信号转导,而过表达则会促进Notch1-NICD信号。在小鼠肝脏中特异性过表达可以挽救BET蛋白抑制对肝脏再生损伤的影响。
这些结果揭示了YAP/TAZ-Notch1-NICD轴在肝脏再生中的关键作用。因此,由于BET蛋白抑制剂在肝脏再生中具有抑制作用,在肝脏疾病治疗中必须谨慎使用。